XTLB Company Profile and Key Details
XTL Biopharmaceuticals Ltd.
XTLB Stock Price Chart
Stock Price Today
XTL Biopharmaceuticals Ltd. (XTLB) stock surged +6.94%, trading at $1.85 on NASDAQ, up from the previous close of $1.73. The stock opened at $1.75, fluctuating between $1.68 and $1.85 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Ramat Gan, Israel.
Company Information
| Employees | 8 |
| Beta | 1 |
| Sales or Revenue | -$459.00K |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB) stock price is $1.85 in the last trading session. During the trading session, XTLB stock reached the peak price of $1.85 while $1.68 was the lowest point it dropped to. The percentage change in XTLB stock occurred in the recent session was 6.94% while the dollar amount for the price change in XTLB stock was $0.12.
The NASDAQ listed XTLB is part of Biotechnology industry that operates in the broader Healthcare sector. XTL Biopharmaceuticals Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Ronen Kantor
Company Sec.
Mr. Shlomo Spokone Shalev
Chief Executive Officer & Director
Mr. Itay Weinstein
Chief Financial Officer
XTLB's closing price is 140.26% higher than its 52-week low of $0.77 where as its distance from 52-week high of $4.99 is -62.93%.
Number of XTLB employees currently stands at 8.
Official Website of XTLB is: https://www.xtlbio.com
XTLB could be contacted at phone 972 361 16600 and can also be accessed through its website. XTLB operates from 5 Badner Street, Ramat Gan, 5218102, Israel.
XTLB stock volume for the day was 1.38K shares. The average number of XTLB shares traded daily for last 3 months was 46.78K.
The market value of XTLB currently stands at $23.21M with its latest stock price at $1.85 and 12.54M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com